Directory profile

Scancell

University of Nottingham-origin immunotherapy company developing cancer vaccine and antibody platforms.

Updated 29 April 2026 · Nottingham Startups index

Profile

Scancell gives Nottingham a serious life-science reference point in immuno-oncology and platform biotechnology. It is relevant for founders because it shows the long arc from academic research through intellectual property, clinical development, public markets and specialist investor communication.

Nottingham link

Originated from University of Nottingham research and remains part of the city’s life-science story.

Sectorhealthtech
Stagegrowth
FundingAIM-listed
Employees50+
Founded1997